Furthermore, the result may help to stratify patients with diffuse or intestinal types of gastric carcinomas, before treatment or after the operation at the time of relapse, for treatment with kinase inhibitors, targeting PDGF-B or VEGF-A receptors. The gene discussed is PDGFB; the disease is gastric carcinoma.